Concepedia

Lawrence S. Blaszkowsky

LS

134

Publications

15.3K

Citations

54

H-Index

1997

Active since

Affiliations

Massachusetts General Hospital(Current)

Harvard University

Dana-Farber Cancer Institute

Brigham and Women's Hospital

Dana-Farber Brigham Cancer Center

Lawrence S. Blaszkowsky is an author at Massachusetts General Hospital specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

1997–2023

134

Publications

134

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

Christopher G. Willett, Yves Boucher, Emmanuelle di Tomaso et al. · Nature Medicine · 2004 · 1.9K citations · Full text

, , +9

Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer

Cristina R. Ferrone, Giovanni Marchegiani, Theodore S. Hong et al. · Annals of Surgery · 2014 · 823 citations · Full text

Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

Manisha H. Shah, Whitney Goldner, Al B. Benson et al. · Journal of the National Comprehensive Cancer Network · 2021 · 542 citations

, , +19

Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma

Janet E. Murphy, Jennifer Y. Wo, David P. Ryan et al. · JAMA Oncology · 2018 · 531 citations · Full text

Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers

Aparna R. Parikh, Ignaty Leshchiner, Liudmila Elagina et al. · Nature Medicine · 2019 · 513 citations

, , +11

Rows per page

1–5 of 134